Mahatma Gandhi Cancer Hospital & Research Institute (MGCHRI) in Visakhapatnam has been ranked ninth among India's leading oncology hospitals.

The recognition highlights the hospital's excellence in comprehensive cancer care, advanced treatment, and patient-focused services.

The achievement further strengthens Visakhapatnam's reputation as an emerging destination for quality healthcare in India.

Mahatma Gandhi Cancer Hospital & Research Institute (MGCHRI), Visakhapatnam, has secured the 9th position among India's top oncology hospitals in the Outlook Best Hospital Rankings 2026. The recognition reflects the institution's continued commitment to delivering advanced cancer care, clinical excellence, and patient-centric treatment.

Established as one of the region's leading comprehensive cancer centres, MGCHRI offers a wide range of oncology services, including medical, surgical, radiation, paediatric, haemato-oncology, bone marrow transplantation, robotic surgery, and advanced diagnostic facilities. The hospital has consistently invested in modern technology and multidisciplinary treatment approaches to improve patient outcomes.

The national ranking acknowledges the hospital's efforts in providing high-quality cancer treatment, research, innovation, and compassionate patient care. Over the years, MGCHRI has served thousands of patients from Andhra Pradesh and neighbouring states, establishing itself as a trusted destination for specialised oncology services.

Healthcare experts believe this achievement will further strengthen Visakhapatnam's standing as a growing healthcare hub in India. The recognition is expected to enhance patient confidence, attract advanced medical collaborations, and encourage continued investment in world-class cancer treatment facilities in the city.